Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes

Dana Boey, Leonie Heilbronn, Amanda Sainsbury, Ross Laybutt, Adamandia Kriketos, Herbert Herzog, Lesley V. Campbell

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Low circulating peptide YY (PYY) levels are reported in obese and type II diabetic subjects and results from PYY knockout animals suggests that PYY deficiency may have a causative role in the etiology of obesity and type 2 diabetes. Here, our aims were to determine whether people with a genetic predisposition to developing type 2 diabetes and obesity differ from otherwise similar subjects without such family history, in fasting or meal-related PYY levels, fasting insulin, insulin secretion (HOMA-B) and insulin sensitivity. We also investigated whether PYY ablation affects the intrinsic ability of islets to secrete insulin, which may be a contributing factor to the hyperinsulinemia observed in PYY knockout mice. Healthy female first-degree relatives of people with type 2 diabetes were matched for age, gender and BMI to control subjects but had significantly lower insulin sensitivity (p < 0.05). Relatives also had significantly lower fasting serum PYY levels than controls (p < 0.05), but their PYY response to a high fat meal (4250 kJ, 73% fat) was not significantly different. Fasting PYY level correlated positively with glucose infusion rate (r = 0.713, p = 0.002) and fasting adiponectin (r = 0.5, p = 0.02). Islets of Langerhans from PYY knockout mice were found to hypersecrete insulin in response to 25 mM glucose (p < 0.05). These data demonstrate that lack of PYY enhances insulin secretion from the Islets of Langerhans and that low fasting PYY levels are associated with insulin resistance in humans. Together, these findings suggest that low circulating levels of PYY could contribute to hyperinsulinemia and insulin resistance, and possibly contribute to subsequent development of obesity and type 2 diabetes.

LanguageEnglish
Pages317-324
Number of pages8
JournalNeuropeptides
Volume40
Issue number5
DOIs
Publication statusPublished - 1 Oct 2006

Keywords

  • First-degree relatives
  • Hyperinsulinemia
  • Insulin
  • Insulin resistance
  • Insulin sensitivity
  • PYY
  • Type II diabetes

ASJC Scopus subject areas

  • Endocrinology
  • Neurology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

Boey, Dana ; Heilbronn, Leonie ; Sainsbury, Amanda ; Laybutt, Ross ; Kriketos, Adamandia ; Herzog, Herbert ; Campbell, Lesley V. / Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. In: Neuropeptides. 2006 ; Vol. 40, No. 5. pp. 317-324.
@article{60572cb921a748b7baca0b1ff5f03575,
title = "Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes",
abstract = "Low circulating peptide YY (PYY) levels are reported in obese and type II diabetic subjects and results from PYY knockout animals suggests that PYY deficiency may have a causative role in the etiology of obesity and type 2 diabetes. Here, our aims were to determine whether people with a genetic predisposition to developing type 2 diabetes and obesity differ from otherwise similar subjects without such family history, in fasting or meal-related PYY levels, fasting insulin, insulin secretion (HOMA-B) and insulin sensitivity. We also investigated whether PYY ablation affects the intrinsic ability of islets to secrete insulin, which may be a contributing factor to the hyperinsulinemia observed in PYY knockout mice. Healthy female first-degree relatives of people with type 2 diabetes were matched for age, gender and BMI to control subjects but had significantly lower insulin sensitivity (p < 0.05). Relatives also had significantly lower fasting serum PYY levels than controls (p < 0.05), but their PYY response to a high fat meal (4250 kJ, 73{\%} fat) was not significantly different. Fasting PYY level correlated positively with glucose infusion rate (r = 0.713, p = 0.002) and fasting adiponectin (r = 0.5, p = 0.02). Islets of Langerhans from PYY knockout mice were found to hypersecrete insulin in response to 25 mM glucose (p < 0.05). These data demonstrate that lack of PYY enhances insulin secretion from the Islets of Langerhans and that low fasting PYY levels are associated with insulin resistance in humans. Together, these findings suggest that low circulating levels of PYY could contribute to hyperinsulinemia and insulin resistance, and possibly contribute to subsequent development of obesity and type 2 diabetes.",
keywords = "First-degree relatives, Hyperinsulinemia, Insulin, Insulin resistance, Insulin sensitivity, PYY, Type II diabetes",
author = "Dana Boey and Leonie Heilbronn and Amanda Sainsbury and Ross Laybutt and Adamandia Kriketos and Herbert Herzog and Campbell, {Lesley V.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1016/j.npep.2006.08.002",
language = "English",
volume = "40",
pages = "317--324",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "5",

}

Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. / Boey, Dana; Heilbronn, Leonie; Sainsbury, Amanda; Laybutt, Ross; Kriketos, Adamandia; Herzog, Herbert; Campbell, Lesley V.

In: Neuropeptides, Vol. 40, No. 5, 01.10.2006, p. 317-324.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes

AU - Boey, Dana

AU - Heilbronn, Leonie

AU - Sainsbury, Amanda

AU - Laybutt, Ross

AU - Kriketos, Adamandia

AU - Herzog, Herbert

AU - Campbell, Lesley V.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Low circulating peptide YY (PYY) levels are reported in obese and type II diabetic subjects and results from PYY knockout animals suggests that PYY deficiency may have a causative role in the etiology of obesity and type 2 diabetes. Here, our aims were to determine whether people with a genetic predisposition to developing type 2 diabetes and obesity differ from otherwise similar subjects without such family history, in fasting or meal-related PYY levels, fasting insulin, insulin secretion (HOMA-B) and insulin sensitivity. We also investigated whether PYY ablation affects the intrinsic ability of islets to secrete insulin, which may be a contributing factor to the hyperinsulinemia observed in PYY knockout mice. Healthy female first-degree relatives of people with type 2 diabetes were matched for age, gender and BMI to control subjects but had significantly lower insulin sensitivity (p < 0.05). Relatives also had significantly lower fasting serum PYY levels than controls (p < 0.05), but their PYY response to a high fat meal (4250 kJ, 73% fat) was not significantly different. Fasting PYY level correlated positively with glucose infusion rate (r = 0.713, p = 0.002) and fasting adiponectin (r = 0.5, p = 0.02). Islets of Langerhans from PYY knockout mice were found to hypersecrete insulin in response to 25 mM glucose (p < 0.05). These data demonstrate that lack of PYY enhances insulin secretion from the Islets of Langerhans and that low fasting PYY levels are associated with insulin resistance in humans. Together, these findings suggest that low circulating levels of PYY could contribute to hyperinsulinemia and insulin resistance, and possibly contribute to subsequent development of obesity and type 2 diabetes.

AB - Low circulating peptide YY (PYY) levels are reported in obese and type II diabetic subjects and results from PYY knockout animals suggests that PYY deficiency may have a causative role in the etiology of obesity and type 2 diabetes. Here, our aims were to determine whether people with a genetic predisposition to developing type 2 diabetes and obesity differ from otherwise similar subjects without such family history, in fasting or meal-related PYY levels, fasting insulin, insulin secretion (HOMA-B) and insulin sensitivity. We also investigated whether PYY ablation affects the intrinsic ability of islets to secrete insulin, which may be a contributing factor to the hyperinsulinemia observed in PYY knockout mice. Healthy female first-degree relatives of people with type 2 diabetes were matched for age, gender and BMI to control subjects but had significantly lower insulin sensitivity (p < 0.05). Relatives also had significantly lower fasting serum PYY levels than controls (p < 0.05), but their PYY response to a high fat meal (4250 kJ, 73% fat) was not significantly different. Fasting PYY level correlated positively with glucose infusion rate (r = 0.713, p = 0.002) and fasting adiponectin (r = 0.5, p = 0.02). Islets of Langerhans from PYY knockout mice were found to hypersecrete insulin in response to 25 mM glucose (p < 0.05). These data demonstrate that lack of PYY enhances insulin secretion from the Islets of Langerhans and that low fasting PYY levels are associated with insulin resistance in humans. Together, these findings suggest that low circulating levels of PYY could contribute to hyperinsulinemia and insulin resistance, and possibly contribute to subsequent development of obesity and type 2 diabetes.

KW - First-degree relatives

KW - Hyperinsulinemia

KW - Insulin

KW - Insulin resistance

KW - Insulin sensitivity

KW - PYY

KW - Type II diabetes

UR - http://www.scopus.com/inward/record.url?scp=33750330611&partnerID=8YFLogxK

U2 - 10.1016/j.npep.2006.08.002

DO - 10.1016/j.npep.2006.08.002

M3 - Article

VL - 40

SP - 317

EP - 324

JO - Neuropeptides

T2 - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 5

ER -